A case of recurrent fixed drug eruption following two different coronavirus disease 2019 vaccination verified through intradermal and patch tests.

Seol, Jung Eun; Ahn, Sang Woo; Jang, Seung Hee; Hong, Seong Min; Kim, Mi Yeong; Kim, Hyojin

Seol, Jung Eun; Ahn, Sang Woo; Jang, Seung Hee; Hong, Seong Min; Kim, Mi Yeong; Kim, Hyojin.

Seol JE; Department of Dermatology, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea.
Ahn SW; Department of Dermatology, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea.
Jang SH; Department of Dermatology, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea.
Hong SM; Department of Dermatology, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea.
Kim MY; Department of Internal Medicine, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea.
Kim H; Department of Dermatology, Busan Paik Hospital, College of Medicine, Inje University, Busan, Korea.

JAAD Case Rep ; 2022 Aug 27.

Article in English | MEDLINE | ID: covidwho-2245051

Keywords

AZD1222; COVID-19 vaccines; drug eruptions; mRNA-1273; polyethylene glycols; polysorbates

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Topics: Vaccines Language: English Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google